ORGO: Organogenesis Holdings Inc. Stock

by  •  • Comments Off on ORGO: Organogenesis Holdings Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 381.83
Enterprise Value ($M) 397.03
Book Value ($M) 368.07
Book Value / Share 2.90
Price / Book 1.04
NCAV ($M) 168.84
NCAV / Share 1.33
Price / NCAV 2.26

Profitability (mra)
Return on Invested Capital (ROIC) -0.04
Return on Assets (ROA) -0.03
Return on Equity (ROE) -0.06

Liquidity (mrq)
Quick Ratio 3.67
Current Ratio 4.12

Balance Sheet (mrq) ($M)
Current Assets 268.16
Assets 467.39
Liabilities 99.33
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 482.04
Operating Income 21.52
Net Income 0.86
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 14.21
Cash from Investing -10.03
Cash from Financing 27.64

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-11 13G/A Soleus Capital Master Fund, L.P. 9.90 5.45
01-13 13D/A Ades Alan A. 17.80
11-19 13D Avista Healthcare Partners III, L.P. 18.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)
2025-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2024 OR ☐ TRANSITION REPORT PUR
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-14 387,160 1,305,813 29.65
2025-05-13 543,539 2,041,899 26.62
2025-05-12 585,388 2,080,991 28.13
2025-05-09 4,227,488 10,779,597 39.22

(click for more detail)

Similar Companies
OKYO – OKYO Pharma Limited ONCO – Onconetix, Inc.
ONCY – Oncolytics Biotech Inc. ORMP – Oramed Pharmaceuticals Inc.
OTLK – Outlook Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io